J&J Coated Stent Launch Expected In All International Markets By May 20
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson must provide regular updates on the long-term performance of its Cypher drug-eluting coronary stent to the British Standards Institution (BSI) following CE mark approval April 12. No postmarket study is required